Chargeability measurements of selected pharmaceutical dry powders to assess their electrostatic charge control capabilities

AAPS PharmSciTech

Volumn 7, Issue 4, 2006, Pages

  Ramirez Dorronsoro, Juan Carlos ^a   Jacko, Robert B ^a   Kildsig, Dane O ^b  

^a PURDUE UNIVERSITY   (United States)

^b PURDUE UNIVERSITY   (United States)

Author keywords

Charge control; Chargeability; Electrostatic; Excipients; Powders; Triboelectricity

Indexed keywords

ALUMINUM; CALCIUM SULFATE; CIMETIDINE; DRUG ADDITIVE; EXCIPIENT; LACTOSE; MAGNESIUM STEARATE; MICROCRYSTALLINE CELLULOSE; PHENYTOIN; SALICYLATE SODIUM; SALICYLIC ACID; SILICON DIOXIDE; SODIUM CARBONATE; STAINLESS STEEL; SULFINPYRAZONE; DRUG;

ACCURACY; ARTICLE; AUTOANALYZER; DRUG FORMULATION; DRY POWDER; ELECTRICITY; EQUIPMENT DESIGN; FEASIBILITY STUDY; MEASUREMENT; PARTICLE SIZE; PROCESS OPTIMIZATION; REPRODUCIBILITY; SURFACE CHARGE; CHEMISTRY; ELECTROCHEMISTRY; EQUIPMENT; INSTRUMENTATION; MATERIALS TESTING; METHODOLOGY; PHARMACEUTICS; POWDER; SENSITIVITY AND SPECIFICITY;

DRUG COMPOUNDING; ELECTROCHEMISTRY; ELECTROSTATICS; EQUIPMENT DESIGN; EQUIPMENT FAILURE ANALYSIS; MATERIALS TESTING; PHARMACEUTICAL PREPARATIONS; POWDERS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; TECHNOLOGY, PHARMACEUTICAL;

EID: 33846545527     PISSN: None     EISSN: 15309932     Source Type: Journal    
DOI: 10.1208/pt0704103     Document Type: Article

References (25)

1. Bailey AG, Hashish AH, Williams TJ. Drug delivery by inhalation of charged particles. J Electrostatics. 1998;44:3-10.
2. Lucas P, Anderson K, Potter UJ, Staniforth JN. Enhancement of small particle size dry powder aerosol formulations using an ultra low density additive. Pharm Res. 1999;16:1643-1647.
3. Zeng XM, Martin GP, Marriot C. Particulate Interactions in Dry Powder Formulations for Inhalations. New York, NY: Taylor and Francis; 2001.
4. Staniforth JN, Rees JE. Electrostatic charge interactions in ordered powder mixes. J Pharm Pharmacol. 1982;34:69-76.
5. Carter PA, Rowley G, Fletcher EJ, Hill EA. An experimental investigation of triboelectrification in cohesive and non-cohesive pharmaceutical powders. Drug Dev Ind Pharm. 1992;18:1505-1526.
6. Rogers B. Difficulties associated with compounding metered-dose inhalers and dry powder inhalers [Powerpoint presentation]. U.S. FDA, Center for Drug Evaluation and Research, Office of New Drug Chemistry, Pharmacy Compounding Advisory Committee. Available at: http://www.fda.gov/ohrms/ dockets/ac/00/slides/3634s1_07_rogers.ppt. Accessed: July 19, 2003.
7. Wade EA, Weller PJ, eds. Handbook of Pharmaceutical Excipients. 2nd ed. Washington, DC: American Pharmaceutical Association; 1994.
8. Cabot Corporation. Cab-O-Sil untreated fumed silica properties and functions [catalog no. TD-100]. Tuscola, IL: Cabot Corporation; 1993.
9. Bavin PMG, Post A, Zarembo JE. Cimetidine. In: Florey K, ed. Analytical Profiles of Drug Substances. vol. 13. Orlando, FL: Academic Press; 1984.
10. Kibbe AH, ed. Handbook of Pharmaceutical Excipients. 3rd ed. Washington, DC: Pharmaceutical Press; 2000.
11. Pujara CP. Determination of Factors That Affect the Generation of Airborne Particles From Bulk Pharmaceutical Powders [thesis]. West Lafayette, IN: Industrial and Physical Pharmacy, Purdue University; 1997.
12. Abounassif MA, Mian MS, Mian AA. Salicylic acid. In: Brittain H, ed. Analytical Profiles of Drug Substances. vol. 23. Orlando, FL: Academic Press; 1994.
13. Sodium Salicylate MSDS. Available at: www.skylighter.com/msds/ sodium_salicylate.txt. Accessed: July 19, 2003.
14. Monograph 8541. Sodium Carbonate. In: Budavary S, ed. The Merck Index. 11th ed. Whitehouse Station, NJ: Merck & Co; 1989.
15. Ghosh R. Pharmaceutical Powder Chargeability and Dustiness Characterization [thesis]. West Lafayette, IN: Purdue University; 1997.
16. Gajewski JB, Szaynok A. Charge measurement of dust particles in motion. J Electrostatics. 1981;10:229-234.
17. USP. US Pharmacopeia National Formulary. Rockville, MD: USP; 1999.
18. Eilbeck J, Rowley G, Carter PA, Fletcher EJ. Effect of contamination of pharmaceutical equipment on powder triboelectrification. Int J Pharm. 2000;195:7-11.
19. Murtomaa M, Harjunen P, Mellin V, Lehto V-P, Laine E. Effect of amorphicity on the triboelectrification of lactose powder. J Electrostatics. 2002;56:103-110.
20. Reis GE, Bierly JN, Schwartz JB. Characterizing electrostatic charge in pharmaceutical powders. Am J Pharm. 1984;156:100-105.
21. Watano S, Suzuki T, Taira T, Miyanami K. Continuous monitoring and mechanism of electrostatic charge of powder in fluidized bed process. Chem Pharm Bull (Tokyo). 1998;46:1438-1443.
22. Murtomaa M, Rasanen E, Rantanen J, et al. Electrostatic measurements on a miniaturized fluidized bed. J Electrostatics. 2003;57:91-106.
23. Swaminathan V, Kildsig DO. Effect of particle morphology on the physical stability of pharmaceutical powder mixtures: effect of surface roughness of the carrier on the stability of ordered mixtures. Drug Dev Ind Pharm. 2000;26:365-373.
24. Bennett FS, Carter PA, Rowley G, Dandiker Y. Modification of electrostatic charge on inhaled carrier lactose particles by addition of fine particles. Drug Dev Ind Pharm. 1999;25:99-103.
25. Zhao H, Castle GSP, Inculet II. The measurement of bipolar charge in polydisperse powders using a vertical array of Faraday pail sensors. J Electrostatics. 2002;55:261-278.